Clostridium Difficile

Labeling and Script Use May Cause Problems For Optimer's New Drug
Seeking Alpha
Fri, 05/27/11 - 08:56 am
Optimer
fidaxomicin
FDA
Clostridium Difficile
Optimer Gets Boost From FDA
Minyanville
Sat, 04/2/11 - 10:14 am
Optimer
fidaxomicin
Clostridium Difficile
Optimer Gets NEJM Power
Forbes
Thu, 02/3/11 - 11:10 am
New England Journal of Medicine
Optimer
fidaxomicin
Clostridium Difficile
Optimer Pharmaceuticals' bacterial infection drug gets 6-month FDA review
Yahoo/AP
Mon, 01/24/11 - 11:46 am
Optimer
FDA
fidaxomicin
Clostridium Difficile
Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile
Yahoo
Mon, 11/29/10 - 11:31 am
Sanofi Pasteur
vaccines
Clostridium Difficile
U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur's Investigational Clostridium difficile Vaccine
Yahoo
Tue, 11/9/10 - 01:15 pm
FDA
fast track
Sanofi Pasteur
Clostridium Difficile
vaccines
Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
PR Newswire
Sun, 10/24/10 - 12:49 pm
Optimer
Clostridium Difficile
fidaxomicin
Progenics gets $4.1M grant for infection treatment
Yahoo/AP
Wed, 10/6/10 - 11:22 am
grants
Progenics Pharmaceuticals
Clostridium Difficile
Optimer's Fidaxomicin Encourages
Yahoo/Zacks.com
Fri, 09/17/10 - 11:09 am
Optimer
fidaxomicin
Clostridium Difficile
Positive Results from Optimer Pharmaceuticals' Second Phase 3 Study of Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) Presented at ECCMID
Yahoo/PR NewsWire
Sun, 04/11/10 - 11:30 am
Optimer
fidaxomicin
Clostridium Difficile
Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
Yahoo/AP
Sun, 11/1/09 - 09:02 am
fidaxomicin
Optimer
Clostridium Difficile

Pages